Diagnosis and treatment of multiple myeloma: current status and future challenges / 白血病·淋巴瘤

ABSTRACT

In the past ten years, much progress has been made in the pathophysiology, risk-stratification, and treatment of multiple myeloma (MM). Emerging paradigms in the therapy of MM including new drugs, chimeric antigen receptor-modified T cells, and allogeneic stem cell transplantation have improved the prognosis of MM patients.